NIH-funded research U01 cooperative agreement

United World Antiviral Research Network (UWARN)

Funded at University of Washington · NIH-11613751 · Data updated 2026-11-12

A global network based at UW, with LMIC partners, aims to study emerging viruses and how they spread, evolve, and affect people living with HIV, to improve antiviral responses.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startMay 22, 2020
Project endJune 30, 2031
Funding year2026
Award (this year)$135,000
NIH project number3U01AI151698-06S3
Project IDNIH-11613751 on NIH RePORTER

Who could benefit from this research

Could help

People living with HIV or other at-risk populations in LMICs, and communities where arboviruses and emerging pathogens are prevalent.

Less likely to help

Individuals not exposed to the studied pathogens or those outside participating regions may not directly benefit.

What this research studies

UWARN is a dedicated research center within CREID, partnering with Brazil, Senegal, and Taiwan, to map and understand how emerging viruses like SARS-CoV-2 and arboviruses behave in real-world settings. The project uses a One Health approach to study viruses in humans, animals, and vectors, and to track how viral evolution correlates with disease outcomes. It builds on prior findings such as new variants and how HIV infection affects viral evolution, and plans to expand collaborations with WRAIR laboratories in Thailand. The work includes genomic surveillance, environmental drivers, and the natural history of infections to inform better detection and control strategies.

Why it matters

Potential benefit: The research could lead to faster detection of dangerous viruses and more effective interventions for people at high risk, including those with advanced HIV.

How similar studies have gone: Previous UWARN work has produced numerous publications and discoveries of variants and regional viral evolution, indicating productive prior efforts.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Rabinowitz, Peter Macgarr — University of Washington
  • Study coordinator: Rabinowitz, Peter Macgarr

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.